ABT - Abbott Labs Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ABT - Abbott Labs

ABT 124.70

+0.2%

3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Hamilton Rogers who wrote (257)	5/24/2000 4:16:00 PM
From: Skywatcher	of 328

TAP launches research with IPF PharmaCeuticals LAKE FOREST, Ill., May 24 (Reuters) - TAP Pharmaceutical Products Inc., a joint venture between Abbott Laboratories (NYSE:ABT - news) and Takeda Chemical Industries Ltd. of Japan, on Wednesday said it launched a long-term research collaboration with Germany's IPF PharmaCeuticals GmbH. TAP said it will provide research funding to IPF for a minimum of five years in return for a right of first refusal to exclusive worldwide development and sales rights to IPF discoveries. IPF, which focuses on research on natural human peptides, will receive an undisclosed sum of money for discoveries and royalties on commercial sales. Lots of potential stuff coming out and after that chart showed a beautiful cup and saucer, the strength continues. chris

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next